Browse By: Country ι Category ι Tag
Home  »  BioInformant

BioInformant Market Research Reports

BioInformant is the global leader in stem cell industry data. As a specialty research company, we use technology to track and identify profit opportunities in stem cell markets and provide this data to clients that require stem cell strategies. We are the only market intelligence company that has specifically served the stem cell sector since it emerged. Our singular focus on this industry allows our team of technology specialists, business analysts, and scientific experts to produce data that enables decision-makers within stem cell companies and organizations to better understand their markets, competitors, and customers. Claim market intelligence that empowers you to learn the key strengths of your competitors, intelligently position your products to fill gaps in the market, and understand crucial trends to stay ahead of your competition. 


Stem Cell Research Products - Opportunities, Tools, and Technologies 2016
Claim this global strategic report to understand unique product opportunities by stem cell type, derive more revenue from products sold to stem cell scientists, and identify new product development opportunities before the competition. Use the “Survey of Stem Cell Scientists” to understand technical requirements, unmet needs, and purchasing preferences of stem cell researchers worldwide.
Published Date: Feb 2016
Published By: BioInformant

Price: $3795
Complete 2015-16 Global Cord Blood Banking Industry Report
The global cord blood banking industry has matured substantially over the past few years, creating both serious threats and novel opportunities. Serious threats to the industry include: New accreditation requirements that have increased the cost structure of cord blood banks A decline in cord blood transplants in 2013, within the U.S. and other geographical regions Low rates of turnover for stored cord blood units Expensive cord blood transplantation procedures, costing from $200-300K each Difficulty with educating obstetricians about cellular therapies Poor press coverage in many regions worldwide, including major news outlets Other uncontrollable factors that could threaten the industry include: new legislation, changes in transplant reimbursement, continually evolving accredi
Published Date: Aug 2015
Published By: BioInformant

Price: $3795
Mesenchymal Stem Cells - Advances & Applications
EXECUTIVE SUMMARY This global strategic report is produced for: Management of stem cell companies Management of regenerative therapy companies Stem cell industry investors It is designed to increase your efficiency and effectiveness in: Commercializing mesenchymal stem cell (MSC) products, technologies, and therapies Making intelligent investment decisions Launching high-demand products Selling effectively to your client base Increasing revenue from MSC products and services Taking market share from your competition  Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells. MSCs are of in
Published Date: Jul 2015
Published By: BioInformant

Price: $4295
The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends
The purpose of this global strategic report is to prepare executives, company management, and industry investors with the data and knowledge necessary to make informed, educated decisions about commercial opportunities within the stem cell biobanking market.  This global strategic report is produced for: Executives of Industrial-Scale Biobanks Management of Stem Cell Product Companies Management of Stem Cell Therapy Companies Biobanking Industry Investors It is designed to increase your efficiency and effectiveness in: Effectively pricing stem cell biobanking services Increasing revenue from stem cell biobanking services Identifying new or adjunct stem cell biobanking services to offer Identifying current market leaders within the stem cell biobanking market Cha
Published Date: Jun 2015
Published By: BioInformant

Price: $1395
Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report
Recent months have seen the first iPSC clinical trial in humans, creation of the world’s largest iPSC biobank, major funding awards, a historic challenge to the “Yamanaka Patent”, a Supreme Court ruling affecting industry patent rights, announcement of an iPSC cellular therapy clinic scheduled to open in 2019, and much more. Furthermore, iPSC patent dominance continues to cluster in specific geographic regions, while clinical trial and scientific publication trends give clear indicators of what may happen in the industry in 2015 and beyond. Is it worth it to get informed about rapidly-evolving market conditions and identify key industry trends that will give you an advantage over your competition?    REPORT APPLICATIONS  This global strategic report is produced for: Managem
Published Date: Apr 2015
Published By: BioInformant

Price: $3795
Complete 2013-14 Induced Pluripotent Stem Cell (iPSC) Industry Report
Stem cell research and experimentation has been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types. The possibilities arising from these characteristics have caused great commercial interest, with potential applications ranging from the use of stem cells in reversal or treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, and more. Diseases such as Huntington’s Chorea, Parkinson’s Disease, and spinal cord injuries are examples of clinical applications in which stem cells could offer benefits in halting or even reversing damage.   Tradition
Published Date: Feb 2014
Published By: BioInformant

Price: $3495
Capitalizing on Opportunities in Cord Blood Industry Growth
The cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as within most developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry, over only a seven year period. This rapid market growth represents both an opportunity to profit, as well as swarming competition. This recently launched industry report "Capitalizing on Opportunities in Cord Blood Industry Growth" addresses this issue by strategically positioning cord blood banks to expand, profit, and outmanoeuvre the competition.  The report also reveals strategies for dominating the global cord blood ban
Published Date: Nov 2013
Published By: BioInformant

Price: $3995
Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017
Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Categorized by stage of life, several broad categories of stem cells exist, including:  Embryonic stem cells, derived from blastocysts  Post-natal stem cells, derived from newborn tissues  Adult stem cells, found in adult tissues – including hematopoietic stem cells, mesenchymal stem cells, neural stem cells, and more  Induced pluripotent stem cells, reprogrammed from adult cells  Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body  Embryonic stem cells are stem cells derived from the inner cell mass of a blastocyst,
Published Date: Oct 2013
Published By: BioInformant

Price: $3495
Complete 2013-14 U.S. Cord Blood Banking Industry Report
The cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as within several developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry in less than a ten-year period. Within the United States, cord blood banks have appeared in nearly every state. Furthermore, the U.S. cord blood banking industry is the most mature cord blood banking market in the world, having the: First company to offer cord blood storage (1995) Early entrant into cord tissue storage (2010) Largest total number of industry participants (both public and private) Most number of cord blood
Published Date: Sep 2013
Published By: BioInformant

Price: $3995
Mesenchymal Stem Cells - Advances & Applications 2013
Understand and profit from the mesenchymal stem cell (MSC) product market – the fastest growing area of stem cell research. Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases. MSCs are advantageous over other stem cells types for a variety of reasons: they avoid the ethical issues that surround embryonic stem cell research, and repeated studies have found MSCs to be immuno-privileged, which make them an advantageous cell type for allogenic t
Published Date: Jun 2013
Published By: BioInformant

Price: $3495
Strategic Development of Neural Stem & Progenitor Cell Products
Overview: Neurogenesis is the process by which neurons are created. This process is most active during pre-natal development when neurogenesis is responsible for populating the growing brain. Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are the progeny of stem cell division that normally undergo a limited number of replication cycles in vivo.  The terms neuronal and neural also need to be defined. Technically speaking, “neuronal” means “pertaining to neurons”, and “neural” means “pertaining to nerves, which are the cordlike bundles of fibers made up of neur
Published Date: Jan 2013
Published By: BioInformant

Price: $3495

Back To Top